The availability of TNF inhibitor biosimilars and the cost of treating ‘difficult-to-treat’ RA are making first-line TNF inhibition in early RA more attractive in the UK.
Dr. Mark S. Komrad has served on the Faculty of Psychiatry at several universities. He is a longtime advocate for safeguarding patients from assisted dying and says psychiatrists are meant to stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results